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Abstract 
Objective: The aim of this study was to compare the response to NO-mediated vasodilators in vivo and in vitro during chronic NO 
synthase inhibition. Methds: NG-Nitro-L-arginine-methyl ester (L-NAME, 0.4 g/l) or vehicle was administered in the drinking water 
for 6 weeks to male Wistar rats weighing 220-240 g. The effect of acetylcholine and sodium nitroprusside was examined in vivo, on 
systemic blood pressure and heart rate and in vitro, on the precontracted isolated mesenteric artery. The in vivo response to both 
vasodilators was examined in awake rats monitored by an indwelling catheter in the femoral artery. Isolated segments of the 
third-generation mesenteric artery were examined in vitro with a Mulvany dual myograph after precontraction with noradrenaline. 
Resultsr In isolated mesenteric arteries obtained from rats chronically treated with L-NAME, the initial relaxant response to acetylcholine 
was significantly decmased whereas that to sodium nitroprusside was enhanced. A late acetylcholine-induced contractile response was 
present and abolished by indomethacin. In vivo, the hypotensive action of sodium nitroprusside was also enhanced in the L-NAME-treated 
rats. Acetylcholine reduced blood pressure in the L-NAME-treated hypertensive animals more than in normotensive controls, but less than 
in control rats infused intravenously with noradrenaline at a dose increasing their blood pressure to hypertensive l vels. Conclusions: The 
NO-mediated vasodilation induced by acetylcholine is attenuated uring chronic NO synthase inhibition, both in vivo and in vitro. The 
blunted hypotensive response to acetylcholine can be demonstrated only if blood pressure of control rats is acutely increased to 
hypertensive l vels. 
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1. Introduction 
The production of nitric oxide (NO) by the vascular 
endothelium is known to play an important role in regulat- 
ing the tone of arterial resistance vessels [l-lo]. Through 
the activation of NO synthase, acetylcholine nhances the 
release of NO from the endothelium and induces a relax- 
ation of the vascular smooth muscle cell [1,8,9]. In vitro, 
this endotheliumdependent response has been shown to be 
inhibited in a dose-dependent manner by NO synthase 
inhibitors and abolished after mechanical removal of the 
endothelium [l,ll]. However, in vivo, NO synthase inhibi- 
tion does not always decrease the hypotensive response to 
acetylcholine [ll-141. Thus, there seems to be a discrep- 
ancy between the in vitro and in vivo responses to acetyl- 
choline. 
The present study was designed to investigate further 
this apparent discrepancy by comparing the in vivo and in 
vitro effects of aceylcholine in rats chronically treated with 
the NO synthase inhibitor, NG-nitro+arginine-methyl es- 
ter (L-NAME). In a first set of experiments, we assessed in
normotensive Wistar rats whether chronic treatment with 
L-NAME alters the responsiveness of their isolated mesen- 
teric arteries to acetylcholine, sodium nitroprusside and 
noradrenaline. Additional in vitro experiments were per- 
formed to explore the contribution of prostaglandins tothe 
arterial responsiveness during NO synthase inhibition. In 
complementary in vivo experiments, the response to the 
same hypotensive agents (e.g., acetylcholine and sodium 
nitroprusside) was tested in intact rats also rendered hyper- 
tensive by chronic NO synthase inhibition. These results 
were compared with those obtained in normotensive Wis- 
tar rats and in Wistar rats exhibiting an increase in blood 
pressure after the acute infusion of noradrenaline. 
2. Methods 
2.1. In vitro studies 
Normotensive male Wistar rats weighing 220-240 g 
(Iffa Credo, Lyon, France) had free access for 6 weeks to 
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Fig. 1. Dose-response curve to noradrenaline in isolated mesenteric arteries obtained from L-NAME-treated rats and their controls. l P < 0.05, L-NAME 
vs. controls (me& f s.e.m.1. 
drinking fluid containing either L-NAME (0.4 g/l of tap environment, with constant emperature and humidity and 
water, Group I, II = 8) or tap water (Group II, II = 7). regular light/dark cycles, and they were fed a regular 
L-NAME was obtained from Sigma Chemie (Buchs, sodium diet (38 mg/day NaCl). At the end of the treat- 
Switzerland). The animals were housed in a conditioned ment period, all animals had their right femoral artery 
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Fig. 2. Percent relaxatioa induced by acetylchohe (lo- 5 M) in isolated mesenteric arteries precontracted with lo+ M noradrenaline, obtained from 
L-NAME-treated rats and their contrds and pretreated or not with indomethacin. * P < 0.05, L-NAME vs. controls (mean fs.e.m.1. 
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Table 1 
Characteristics of the study groups examined in vitro (mesa f s.e.m.) 
n BW 
LiZid Em) 
L-NAME lndomethacin 
Cd (ia viva) (in vitro) 
I 8 378f13.9 l 1925 3.2 l 462*19 + - 
II 7414*6.5 126f 3.5 444*7- - 
III 7 344f 9.5 l 193k 7.0 l 498&U l + + 
IV 8 405f13.6 130* 14 391f14 - + 
BW = body weight; MAP = mesa intra-arterial pressure; HR = heart rate; 
+ = procedure done; - = procedure not done. l P < 0.05 versus corre- 
spoadiag controls. 
Table 2 
characteristics of the stady groups examined ia vivo (mean 5 s.e.m.) 
n 
$I EZd 
HR 
(bpm) 
Ch~Oi 9 403k6 134*2 369* 7 
L-NAME 7 395f9 181k5 l + 406f18’ 
Noradnasline 7 407It3 160*3 l 329f16 
BW = body weight; MAP = mean iatra-arterial pressure; I-IR = hesrt rate. 
l P < 0.05 versus controls. ’ P < 0.05 versus aorsdreasliae. 
instrumented with a catheter (PE50) containing a hep 
arinked 0.9% NaCl solution. This was done under 
halothane anesthesia the day before hemodynamic mea- 
surements were performed. The animals were then re- 
turned to their cage. 
On the study day, they were placed in a plastic tube for 
partial restriction of their movements. In&a-arterial pres- 
sure and heart rate were monitored after 1 h rest using a 
computerized ata acquisition system [15]. The animals 
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Fig. 4. Biphssic response induced by acetylcholme (10m5 M) ia sn 
isolated mesentezic artery precontracted with 10m5 M noradrenaliae. This 
artery was obtained from a L-NAME-treated rat. In this example, baseline 
wss at 6.8 mN. Acetylcholine induced a relaxation (-0.7 mN from 
baseline) followed by a contraction ( + 0.6 mN from bsseline). 
were then anesthetized with halothane and a 2 mm length 
segment of the third-generation mesenteric artery (100-150 
pm diameter) was dissected and suspended on two tung- 
sten wires (25 pm diameter) and mounted on stainless 
steel gains in a Mulvany dual myograph [16]. The bath 
medium surrounding the arteries consisted of an oxy- 
genated, warmed (37°C) physiological salt solution of the 
following composition (mM): NaCl 119, KCL 4.7, 
KH*PO, 1.17, NaHC03 25, MgSO, 1.17, CaCl, 2.5, 
glucose 5.5. After having been stretched in steps under 
micrometer control, each artery was set at an internal 
circumference of 0.9 X LIoO where L,, is the internal 
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Fig. 3. Percent ~tractioa induced by scetyld~~line (10M5 M) ia isolated mesenteric arteries prec~r~tracted with lo-’ M noradrenaline, obtained from 
L-NAME-treated rata and their controls and pretreated or not with indomethacia. l P < 0.05, L-NAME vs. controls (mesafs.e.m.). 
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circumference the artery would have had in vivo when 
relaxed and under a transmural pressure of 100 mmHg 
1161. The starting tension of each artery was the same and 
the active tension induced by noradrenaline was expressed 
as a function of the starting tension. After 1 h rest in the 
drug-free physiological salt solution, the arteries were 
challenged with increasing doses of noradrenaline (lo-s- 
10m5 M, Sigma). Once the contraction with noradrenaline 
10m5 M was achieved, acetylcholine 10e5 M (Sigma) was 
introduced into the bath. The peak relaxation and/or 
contraction was calculated according to the maximal con- 
traction with noradrenaliie. The same experiment was 
performed with sodium nitroprusside lo-’ M (Hofmann-La 
Roche, Basel, Switzerland) instead of acetylcholine after a 
wash-out period of 1 h. 
Identical segments of the mesenteric arteries were ex- 
amined from other ats treated either with L-NAME (Group 
III, n = 7) or tap water (Group IV, n = 8). In order to test 
the influence of prostaglandins on the response to the 
vasoactive agents, the same experiments were performed 
after introduction of the cyclo-oxygenase inhibitor in- 
domethacin at 10e5 M (Merck Sharp, Dohme-Chibret, 
Glattbrugg, Switzerland) into the physiological salt solu- 
tion. 
A separate xperiment was performed in order to study 
the ratio % acetylcholine-induced relaxation / % sodium 
nitroprusside-induced relaxation as a marker of NO syn- 
thase inhibition. As acute NO synthase inhibition decreases 
acetylcholine-induced relaxation and does not modify or 
increases odium-nitropruside-induced r laxation, it can be 
assumed that this ratio decreases during NO synthase 
inhibition. Four segments of the third-generation mesen- 
teric artery obtained from control rats were mounted in the 
Mulvany myograph as described above. The relaxant re- 
sponse to acetylcholine lo-’ M and to sodium nitroprus- 
side 10V5 M was tested on the arteries pretreated with 
indomethacin lo-* M and precontracted with nora- 
drenaline lo- 5 M. After a wash-out period of 1 h, the 
same experiments were repeated with L-NAME 10T6 M in 
the bath medium. Indomethacin and L-NAME were intro- 
duced into the bath medium 5 min before noradrenaline. 
The relaxation induced by acetylcholine and sodium nitro- 
prusside was expressed as the percent decrease from the 
contraction induced by noradrenaline low5 M. The ratio 
described above was then calculated twice for each artery: 
with and without L-NAME in the bath medium. 
2.2. In vivo studies 
Normotensive male Wistar rats weighing 220-240 g 
were treated for 6 weeks with L-NAME (0.4 g/l of 
drinking water, n = 7) or tap water (n = 16). At the end of 
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Fii. 5. Percent relaxation induced by sodium nitropmsside (lo-’ M) in isolated mesente& arteries precontracted with 10s5 M no&mnab. obtained 
from L-NAME-treated rats and their controls and pretreated or not with indometbcin. l P < 0.05, L-NAME vs. controls (meanfs.e.m.). 
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the treatment period, all animals were instrumented with a 
catheter (PE50) into the right femoral artery and vein, 
respectively. This was done under halothane anesthesia the 
day before the hemodynamic measurements were per- 
formed. On the study day, the animals were placed in a 
plastic tube for partial restriction of their movements. 
Intra-arterial pressure and heart rate were monitored after a 
1 h rest. In 7 of the rats receiving tap water, noradrenaline 
was infused intravenously for 15 min at a rate of 500 
ng/min (5 pl/min) in order to increase the baseline 
blood pressure by approximately 30 mmHg. It was felt 
unethical to increase acutely the blood pressure in these 
conscious rats to the levels similar to those found after 
chronic NO synthase inhibition. 
In all rats, sodium nitroprusside was then infused via 
the intravenous catheter at increasing doses (1.25, 2.5, 5 
pg/min). Each dose was given during a period of 5 min. 
The same procedure was done after 1 h rest with increas- 
ing doses of acetylcholine (3.75, 7.5, 15 pg/min). Both 
test agents were diluted in 0.9% NaCl (sodium nitroprus- 
side, 1.25 fig/l0 ~1; acetylcholine, 3.75 kg/l0 1.~11. 
2.3. Statistics 
The dose-response curves to norepinephrine in vitro, 
acetylcholine and sodium nitroprusside in vivo were anal- 
ysed by an analysis of variance for repeated measures. 
When two sets of values were compared as with the values 
Mean blood pressure 
(96 of basclinc) 
Mean blood prcssurc 
(5% of basclinc) 
of blood pressure, body weight, heart rate and relaxation to 
acetylcholine or sodium nitroprusside in vitro, Student’s 
unpaired t-test was used A value of P < 0.05 was consid- 
ered significant. Data are reported as mean f s.e.m. 
3. Results 
3.1. In vitro studies 
Body weight (BW), mean arterial blood pressure (MAP) 
and heart rate (HR) of treatment Groups I to IV are shown 
in Table 1. L-NAME-treated rats gained less weight than 
the controls. L-NAME induced a marked increase in MAP 
and a slight rise in heart rate when the groups with similar 
treatments in vivo were grouped together (I + III 481 f 13 
bpm, n = 15 vs. II + IV 412 f 12 bpm, n = 15; P < 
0.001). 
In vitro, mesenteric arteries obtained from the L- 
NAME-treated rats contracted less in response to nora- 
drenaline than those obtained from controls (Fig. 1). The 
acetylcholine-induced relaxation was significantly attenu- 
ated in the precontracted arteries obtained from the L- 
NAME-treated rats (Fig. 2). With indomethacin, the relax- 
ation tended to be enhanced in both groups. 
A contractile response to acetylcholine was only ob- 
served in the arteries obtained from the L-NAME-treated 
rats (Fig. 3). This was preceded by a small vasodilatory 
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70 - Nondrrnalinc(n-7) 
Acctylcholine pg/min 
conlcolr (n-9) 
~ondmvlinc 0-n
LNAME(n=7) 
:t---- 
I.25 2.5 5 
Sodium nitroprusside pg/min 
Fig. 6.~~inmeanbloodpnswres,~xpressedin%ofbaseline,induadinconcious L-NAME,coII&oI aud~omdrcnalh-infwedmts byincreasing 
d0se of aCetylch0liUc end sodium nitropnrsside (m an f s.e.m.). 
A. Zanchi et al. / Cardiouascular Research 30 (1995) 122-129 127 
Heart rate (bpm) 
Heart rate (bpm) 
Controls (n=9) 
L-NAME (~7) 
Noradmaliie h=7) 
3.75 7.5 IS 
Acetylcholine p.g/min 
550- 
x)0- 
450 - 
400- 
350 - 
L-NAME (1x17) 
NOllUhMb ’ (n=7) 
cordrols (Id) 
300’ 
1.25 2.5 5 
Sodium nitroprusside pg/min 
Fig. 7. Effect of increasing doses of acetylcholine (upper panel) and sodium nitroprusside (lower panel) on heart rate of L-NAME, control and 
noradrenaline-infused rats (mean f s.e.m.). 
response (Fig. 4). The contractile response was no longer 
present with indomethacin, suggesting a prostaglandin- 
mediated response (Fig. 3). 
The relaxant response to sodium nitroprusside was en- 
hanced in the arteries obtained from the L-NAME-treated 
rats and indomethacin did not change the response (Fig. 5). 
When mesenteric arteries obtained from control rats are 
exposed to L-NAME lob6 M in vitro, the % 
acetylcholine-induced relaxation / 70 sodiwn nitroprus- 
side-induced relaxation ratio was significantly decreased 
compared to the values obtained with the same arteries 
held in the bath without L-NAME (L-NAME vs. controls, 
0.49 f0.07 vs. 0.96 f0.14, P<O.O5). When the ratio 
was compared between the arteries obtained from the 
L-NAME-treated rats (L-NAME only given in viva) and 
control rats, the difference was highly significant (L-NAME 
vs. controls, without indomethacin (Groups I and II): 
0.14 f 0.05 vs. 0.68 f 0.18; L-NAME vs. controls, with 
indomethacin (Groups III and IV): 0.25 f 0.08 vs. 1.42 f 
0.12, P < 0.001). The ratio was decreased to a larger 
extent in the arteries obtained from the rats treated with 
L-NAME in vivo than in those treated with L-NAME only 
in vitro. 
3.2. In vivo stzufies 
The characteristics of the study groups are presented in 
Table 2. Sodium nitroprusside (5 &mitt) reduced blood 
pressure in the L-NAME-treated rats by 26.5% as com- 
pared to the 10.8% reduction observed in the controls and 
the 17.8% reduction in the noradrenaline-infused rats P < 
0.001, L-NAME vs. controls and L-NAME vs. nora- 
drenaline) (Fig. 6). Surprisingly, acetylcholine (15 pg/ 
min) also reduced blood pressure markedly more in L- 
NAME-treated animals (26%) than in the controls (16.3%). 
However, the noradrenaline-infused rats exhibited an even 
blood pressure fall of 29% (Fig. 6). The dose-response 
curves with acetylchohne were all significantly different 
from each other when analysed by repeated measures 
analysis of variance (P < 0.05). This was also the case for 
the dose-response curves established with sodium nitro- 
prusside. The decrease in blood pressure was associated 
with a comparable increase in heart rate in the three groups 
(Fig. 7). 
4. Discussion 
Chronic administration of L-NAME in drinking water 
(0.4 g/l) during 6 weeks decreases NO synthase activity in 
the rat brain to less than 16% [17]. It has however not yet 
been demonstrated whether NO synthase remains inhibited 
in vitro when the arteries are obtained from rats chroni- 
cally treated with an NO synthase inhibitor. In vascular 
preparations, the acetylcholine-induced relaxation disap 
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pears completely after endothelial removal [ll. With an 
intact endothelium, it is inhibited in a concentration-depen- 
dent manner by adding NO synthase inhibitors in vitro 
[ll]. The response to acetylcholine is often used as an 
indicator of NO synthase activity, but acetylcholine may 
act on the endothelium by ways which are not NO-syn- 
thase-dependent, such as by releasing the endothelial-de- 
rived contracting factor (EDCF) or the endothelial-derived 
hyperpolarizing factor (EDHF). This is why we also exam- 
ined the response to sodium nitroprusside which is known 
to be enhanced uring NO synthase inhibition [l&19]. Our 
data show that the in vitro response to one dose of 
acetylcholine is blunted and that to one dose of sodium 
nitroprusside is enhanced in the mesentric arteries obtained 
from rats chronically treated with L-NAME. These data 
should be interpreted with caution since full dose-re- 
sponse curves were not available and the degree of con- 
traction during exposure to noradrenaline lo-’ M was 
lower in L-NAME-treated than in control rats. However, 
considering these limitations, these results suggest that 
some NO synthase inhibition still persists in vitro. This is 
further supported by the observation that the ratio % 
acetylcholine-induced relaxation / 90 sodium nitroprus- 
side-induced relaxation used as an indicator of NO syn- 
thase inhibition accentuated the differences between the 
L-NAME-treated group and the control group. The ratio 
was lower when L-NAME was administered chronically to 
the rat than when L-NAME was only administered in vitro. 
This discrepancy could be related to a difference in L- 
NAME concentrations atthe level of the artery in vivo and 
in vitro or to possible endothelial damage occurring as a 
consequence of chronic hypertension in the L-NAME- 
treated rats. 
Incubation with the cycle-oxygenase inhibitor in- 
domethacin has been reported to alter the relaxation re- 
sponse to acetylcholine and to reduce the inhibitory effects 
of NO synthase inhibition [20,21]. In our experiment, 
indomethacin enhanced the relaxant response to acetyl- 
choline in arteries obtained from the L-NAME-treated rats 
and from controls, but did not change the response to 
sodium nitroprusside in both groups. In the arteries ob- 
tained from the control rats and exposed to indomethacin, 
the relaxant response was higher with acetylcholine than 
with sodium nitroprusside. This difference may be related 
to another relaxant factor than NO released by acetyl- 
choline, such as the hyperpolarizing factor (EDHF). This 
hypothesis was not tested in our study. 
Interestingly, only the arteries obtained from the L- 
NAME-treated rats exhibited a contractile response to 
acetylcholine. Under normal circumstances, acetylcholine 
may release sufficiently high quantities of NO to mask the 
effect of EDCF. During NO synthase inhibition, acetyl- 
choline-induced contraction is observed as a late response, 
presumably reflecting the inability of NO synthase to 
release enough NO. The fact that this contractile response 
is inhibited with the cycle-oxygenase inhibitor, in- 
domethacin, strongly suggests that the action of EDCF is 
prostaglandin-mediated. Recent studies [21,22] using spe- 
cific prostaglandin inhibitors demonstrated that prosta- 
glandin H, (PGH,) is a strong candidate for the vasocon- 
striction caused by acetylcholine. In these experiments 
performed on the rat aorta, indomethacin presumably in- 
hibited the production of PGH, and thereby prevented the 
contractile response induced by high concentrations of 
acetylcholine (> lo-’ Ml. Thus, the inhibition of EDCF 
by indomethacin may result in an increased relaxant re- 
sponse to acetylcholine, as observed in our study. 
In vitro, both removal of the endothelium and acute NO 
synthase inhibition increases the catecholamine-induced 
vasoconstriction [18,20]. Such an effect on noradrenaline 
responses was not found in our arteries obtained from 
chronically L-NAME-treated rats. Quite to the contrary, the 
arterial responsiveness to a-adrenoreceptor stimulation was 
blunted by in vivo NO synthase inhibition. In the rats 
chronically treated with a NO synthase inhibitor, there 
might be a counter-regulatory phenomenon decreasing the 
responsiveness to catecholamines. In our L-NAME-treated 
rats, a 3-fold increase in plasma noradrenaline levels was 
observed [17]. Persistent high levels of catecholamines can 
lead to a down-regulation of cr-adrenoreceptors 1231 and 
could explain the decreased contractile response to nora- 
drenaline in this model. 
The hypotensive response to sodium nitroprusside was 
significantly enhanced in the L-NAME-treated rats. These 
results are similar to those reported previously [l&24,25] 
and to the response found in vitro in thii study. The 
attenuated response to acetylcholine could only be demon- 
strated when comparing the L-NAME-treated rats with the 
noradrenaline-infused rats. Indeed, with the infusion of 
noradrenaline, the baseline levels of blood pressure are 
more comparable to those of the L-NAME-treated rats. 
Since the baseline blood pressure was still significantly 
lower in the noradrenaline-infused group than in the L- 
NAME-treated group, it can be speculated that the hy- 
potensive response to acetylcholine might have been even 
greater with a dose of noradrenaline inducing the same 
increase in blood pressure as L-NAME. Furthermore, as 
the baseline tension was the same in all arteries in vitro, it 
seems particularly logical to compare the results obtained 
in vitro with those obtained in the groups having the 
closest baseline blood pressure levels in vivo. Indeed, the 
response to acetylcholine in vivo involves the whole car- 
diovascular system with its counter-regulatory mechanisms 
and in many ways can differ from the local action of 
acetylcholine on vascular tone. Nevertheless, these results 
demonstrate that the response to acetylcholine in vivo 
parallels that found in vitro when the blood pressure of the 
control animals is somewhat comparable to that of the 
L-NAME-treated rats. 
In conclusion, chronic administration of L-NAME for 6 
weeks induced severe hyperteusion. NO synthase inhibi- 
tion persisted in isolated mesenteric arteries obtained from 
rats chronically treated with the NO synthase inhibitor. 
This was indicated by the fact that the acetylcholine-in- 
duced relaxation remained reduced, the sodium-nitroprus- 
side-induced relaxation was enhanced and the late acetyl- 
choline-induced contractile response occurred only in the 
L-NAME-treated rats. This latter effect was prevented 
when the isolated arteries were pretreated with in- 
domethacin, suggesting a prostaglandin-mediated me-cha- 
nism. In vivo, the attenuated response to acetylcholine 
could be demonstrated in the control hypertensive rats 
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infused with noradrenaline but not in the normotensive 
control rats. These results demonstrate that there is no 
discrepancy between the response to acetylcholine in vivo 
and in vitro after NO synthase inhibition if the intra-arterial 
blood pressure of the control animals is increased to levels 
close to those of L-NAME-treated animals. 
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